These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Disseminated molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus: efficacy of cidofovir]. Fery-Blanco C; Pelletier F; Humbert P; Aubin F Ann Dermatol Venereol; 2007 May; 134(5 Pt 1):457-9. PubMed ID: 17507844 [TBL] [Abstract][Full Text] [Related]
5. Molluscum contagiosum infection associated with pimecrolimus use in pityriasis alba. Goksugur N; Ozbostanci B; Goksugur SB Pediatr Dermatol; 2007; 24(5):E63-5. PubMed ID: 17958783 [TBL] [Abstract][Full Text] [Related]
6. Adults with atopic dermatitis and herpes simplex and topical therapy with tacrolimus: what kind of prevention? Lübbe J; Sanchez-Politta S; Tschanz C; Saurat JH Arch Dermatol; 2003 May; 139(5):670-1. PubMed ID: 12756112 [No Abstract] [Full Text] [Related]
7. Clinical inquiries. What is the role of tacrolimus and pimecrolimus in atopic dermatitis? Trammell S; Shakil A; Wilder L; Daugird A J Fam Pract; 2005 Aug; 54(8):714-6. PubMed ID: 16061062 [No Abstract] [Full Text] [Related]
8. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis]. de Bruin-Weller MS; Bruijnzeel-Koomen CA Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135 [TBL] [Abstract][Full Text] [Related]
9. Eczema herpeticum in a patient with atopicdermatitis treated with topical tacrolimus. Khalid A; Mc Dermott H; Merry C; Bergin C Ir Med J; 2005; 98(7):220-1. PubMed ID: 16185024 [No Abstract] [Full Text] [Related]
10. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis]. van der Laan JR Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1816; author reply 1817. PubMed ID: 16121669 [No Abstract] [Full Text] [Related]
11. [Calcineurin inhibitors in treatment of atopic dermatitis. Topical corticoids now only in severe outbreaks? ]. MMW Fortschr Med; 2003 Jul; 145(29-30):62. PubMed ID: 12958787 [No Abstract] [Full Text] [Related]
12. Topical tacrolimus in the management of atopic dermatitis in Japan. Furue M; Uchi H; Moroi Y; Ogawa S; Nakahara T; Urabe K Dermatol Ther; 2006; 19(2):118-26. PubMed ID: 16669995 [TBL] [Abstract][Full Text] [Related]
13. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. Berger TG; Duvic M; Van Voorhees AS; VanBeek MJ; Frieden IJ; J Am Acad Dermatol; 2006 May; 54(5):818-23. PubMed ID: 16635663 [No Abstract] [Full Text] [Related]
14. Topical tacrolimus in the treatment of atopic dermatitis--does it benefit the airways? A 4-year open follow-up. Virtanen H; Remitz A; Malmberg P; Rytilä P; Metso T; Haahtela T; Reitamo S J Allergy Clin Immunol; 2007 Dec; 120(6):1464-6. PubMed ID: 17910892 [No Abstract] [Full Text] [Related]
15. Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. Fonacier L; Spergel J; Charlesworth EN; Weldon D; Beltrani V; Bernhisel-Broadbent J; Boguniewicz M; Leung DY; ; J Allergy Clin Immunol; 2005 Jun; 115(6):1249-53. PubMed ID: 15940142 [No Abstract] [Full Text] [Related]
16. Facial eruption of viral warts in a child treated with 0.03% tacrolimus ointment for atopic dermatitis. Patrizi A; Neri I; Bianchi F; Passarini B; Ricci G Pediatr Dermatol; 2007; 24(4):445-7. PubMed ID: 17845188 [No Abstract] [Full Text] [Related]
17. Relationship between Kaposi's varicelliform eruption in Japanese patients with atopic dermatitis treated with tacrolimus ointment and genetic polymorphisms in the IL-18 gene promoter region. Osawa K; Etoh T; Ariyoshi N; Ishii I; Ohtani M; Kariya S; Uchino K; Kitada M J Dermatol; 2007 Aug; 34(8):531-6. PubMed ID: 17683383 [TBL] [Abstract][Full Text] [Related]
18. Alcohol-induced rash caused by topical tacrolimus. Knight AK; Boxer M; Chandler MJ Ann Allergy Asthma Immunol; 2005 Sep; 95(3):291-2. PubMed ID: 16200821 [TBL] [Abstract][Full Text] [Related]
19. [Topical immune modulation and risk of cancer]. Deleuran M; Zachariae C; Thestrup-Pedersen K Ugeskr Laeger; 2009 Aug; 171(35):2468-71. PubMed ID: 19732533 [TBL] [Abstract][Full Text] [Related]